In five of the 51 ovarian cancer patients without a germline BRCA1 or BRCA2 mutation included in this study, a somatic, pathogenic mutation affecting BRCA1 or BRCA2 was encountered. The gene discussed is BRCA2; the disease is ovarian cancer.